title: Vemurafenib-induced pulmonary injury.
authors.affiliation: Department of Dermatology, Klinikum Ludwigshafen, Skin Cancer Center Rheinpfalz, Germany.
authors.forename: Laurenz
authors.initials: L
authors.lastname: Schmitt
authors.forename: Tamara
authors.initials: T
authors.lastname: Schumann
authors.forename: Christoph
authors.initials: C
authors.lastname: Löser
authors.forename: Edgar
authors.initials: E
authors.lastname: Dippel
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D055370:Lung Injury / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control*; D008545:Melanoma / Q000150:complications / Q000188:drug therapy* / Q000556:secondary*; D008875:Middle Aged; D013449:Sulfonamides / Q000009:adverse effects*; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib